AEON Biopharma, Inc. (AEON)
0.1616
0.00 (0.00%)
USD |
NYAM |
Nov 06, 10:20
AEON Biopharma EPS Diluted (Quarterly) : -0.0229 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0229 |
| March 31, 2026 | -0.2904 |
| December 31, 2025 | -3.068 |
| September 30, 2025 | -0.39 |
| June 30, 2025 | -0.5989 |
| March 31, 2025 | 2.282 |
| December 31, 2024 | 3.749 |
| September 30, 2024 | -0.1562 |
| June 30, 2024 | 4.225 |
| March 31, 2024 | -3.167 |
| December 31, 2023 | -50.82 |
| September 30, 2023 | -630.44 |
| Date | Value |
|---|---|
| June 30, 2023 | -7.976 |
| March 31, 2023 | -9.148 |
| December 31, 2022 | -17.92 |
| September 30, 2022 | -5.413 |
| June 30, 2022 | 0.0541 |
| March 31, 2022 | 0.0804 |
| December 31, 2021 | 0.0072 |
| September 30, 2021 | 0.205 |
| June 30, 2021 | -0.1167 |
| March 31, 2021 | 0.2882 |
| December 31, 2020 | -0.0001 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.305 |
| Alnylam Pharmaceuticals, Inc. | 15.72 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.155M |
| Total Expenses (Quarterly) | 1.155M |
| Enterprise Value | 3.503M |
| Earnings Yield | -2.33K% |
| Normalized Earnings Yield | -1610.89 |